• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

2. Diabetes C, Complications Trial Research G, Nathan DM, et al. The impact of intensive therapy of diabetes on the development and progression of lengthy-time period complications in insulin-dependent diabetes mellitus. N Engl J Med. 3. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. 4. Intensive blood-glucose control with sulphonylureas or insulin in contrast with typical therapy and BloodVitals SPO2 threat of complications in patients with sort 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. 5. Stratton IM, Adler AI, Neil AW, Matthews DR, et al. Association of glycaemia with macrovascular and microvascular complications of kind 2 diabetes (UKPDS 35): potential observational examine. 6. Parkin CG, BloodVitals SPO2 Buskirk A, Hinnen DA, Axel-Schweitzer M. Results that matter: structured vs. 2 diabetes. Diabetes Res Clin Pract. 7. Schnell O, Alawi H, Battelino T, et al. Self-monitoring of blood glucose in kind 2 diabetes: recent studies.

J Diabetes Sci Technol. 8. Cavalot F, Pagliarino A, Valle M, et al. Postprandial blood glucose predicts cardiovascular events and all-trigger mortality in type 2 diabetes in a 14-12 months comply with-up: lessons from the San Luigi Gonzaga Diabetes Study. 9. Inzucchi SE, Bergenstal RM, Buse JB, et al. Management of hyperglycemia in type 2 diabetes: a affected person-centered approach: position assertion of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). 11. Boutati EI, Raptis SA. Self-monitoring of blood glucose as a part of the integral care of sort 2 diabetes. 12. Klonoff DC, Blonde L, Cembrowski G, BloodVitals SPO2 et al. Consensus report: the current position of self-monitoring of blood glucose in non-insulin-treated sort 2 diabetes. J Diabetes Sci Technol. 13. Ceriello A, Barkai L, Christiansen JS, et al. Diabetes as a case examine of chronic disease management with a personalised method: The function of a structured feedback loop.

Diabetes Research and Clinical Practice. 14. Malanda UL, Welschen LMC, Riphagen II, BloodVitals SPO2 Dekker JM, Nijpels G, Bot SDM. Self-monitoring of blood glucose in patients with type 2 diabetes mellitus who aren't utilizing insulin. Cochrane Database of Systematic Reviews. 15. Polonsky WH, Fisher L, Schikman CH, et al. Structured Self-Monitoring of Blood Glucose Significantly Reduces A1C Levels in Poorly Controlled, Noninsulin-Treated Type 2 Diabetes: BloodVitals monitor Results from the Structured Testing Program research. 16. Young LA, Buse JB, Weaver MA, et al. Glucose self-monitoring in non-insulin-treated patients with kind 2 diabetes in primary care settings: A randomized trial. 17. Kempf K, Kruse J, Martin S. ROSSO-in-praxi: a self-monitoring of blood glucose-structured 12-week life-style intervention significantly improves glucometabolic management of patients with kind 2 diabetes mellitus. 18. Hortensius J, Kars MC, Wierenga WS, Kleefstra N, Bilo HJ, van der Bijl JJ. Perspectives of patients with sort 1 or insulin-handled type 2 diabetes on self-monitoring of blood glucose: a qualitative study.

19. Childs BP, Grothe JM, BloodVitals SPO2 Greenleaf PJ. Strategies to Limit the Effect of Hypoglycemia on Diabetes Control: Identifying and Reducing the Risks. 20. McQueen R, Ellis S, Maahs D, Anderson H, Nair K, Campbell J. Frequency of Continuous Glucose Monitoring Use and change in Hemoglobin A1C for Adults with Type 1 Diabetes in a Clinical Practice Setting. 21. Gonder-Frederick L, Nyer M, Shepard JA, Vajda K, BloodVitals SPO2 Clarke W. Assessing worry of hypoglycemia in children with Type 1 diabetes and their mother and father. 22. Copeland BloodVitals SPO2 KC, Silverstein J, Moore KR, et al. Management of newly diagnosed kind 2 Diabetes Mellitus (T2DM) in kids and adolescents. 23. Standards of Medical Care in Diabetes--2018. Diabetes Care. Jan; 41(Supplement 1): S3-S3. 24. Barry HG. Factors Affecting Blood Glucose Monitoring: Sources of Errors in Measurement. Journal of Diabetes Science and Technology. 25. Jing W, Janice Z, BloodVitals SPO2 Judith TM, Denise C-P, Susan MS, Linda S. Self-Monitoring of Blood Glucose Is Related to Problem-Solving Skills in Hyperglycemia and Hypoglycemia.

26. Cohen RM, Lindsell CJ. When the Blood Glucose and the HbA1c Don’t Match: Turning Uncertainty Into Opportunity. 27. Hirsch IB, Amiel SA, Blumer IR, et al. Using Multiple Measures of Glycemia to Support Individualized Diabetes Management: BloodVitals health Recommendations for Clinicians, Patients, and Payers. Diabetes Technology & Therapeutics. 28. Tenderich A. Use of Blood Glucose Meters Among People With Type 2 Diabetes: Patient Perspectives. 29. Cypress M, Tomky D. Using Self-Monitoring of Blood Glucose in Noninsulin-Treated Type 2 Diabetes. 30. Grady M, Pineau M, Pynes MK, Katz LB, Ginsberg B. A Clinical Evaluation of Routine Blood Sampling Practices in Patients with Diabetes: Impact on Fingerstick Blood Volume and Pain. Journal of Diabetes Science and Technology. 31. Miller KM, Beck RW, Bergenstal RM, et al. Evidence of a strong association between frequency of selfmonitoring of blood glucose and hemoglobin A1c ranges in T1D alternate clinic registry contributors. 32. Poolsup N, Suksomboon N, Rattanasookchit S. Meta-analysis of the advantages of self-monitoring of blood glucose on glycemic control in type 2 diabetes patients: an update. 33. Klonoff DC, Lias C, Beck S, et al. Development of the Diabetes Technology Society Blood Glucose Monitor System Surveillance Protocol. J Diabetes Sci Technol. 34. Kitzmiller JL, Block JM, Brown FM, et al. Managing preexisting diabetes for BloodVitals insights pregnancy: summary of proof and consensus suggestions for care.